Patents by Inventor Edward C. Meek

Edward C. Meek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL OXIMES FOR REACTIVATING BUTYRYLCHOLINESTERASE
    Publication number: 20170258774
    Abstract: Oxime molecules for reactivating butyrylcholinesterase (BChE) and methods for protection against and therapeutic treatment of the toxic effects of organophosphorus compounds (OP) cholinesterase inhibitors such as nerve agents and/or insecticides are provided. The oxime molecules can be administered to a subject in need thereof to treat or prevent toxic effects of OPs. The oxime molecules can allow for a dual reactivation treatment paradigm by reactivating both serum BChE and inactivated CNS AChE.
    Type: Application
    Filed: March 14, 2017
    Publication date: September 14, 2017
    Applicant: MISSISSIPPI STATE UNIVERSITY
    Inventors: Janice E. Chambers, Howard W. Chambers, Edward C. Meek
  • Phenoxyalkyl pyridinium oxime therapeutics for treatment of organophosphate poisoning
    Patent number: 9227937
    Abstract: Phenoxyalkyl pyridinium oxime compounds for use in treating organophosphate poisoning.
    Type: Grant
    Filed: May 12, 2011
    Date of Patent: January 5, 2016
    Assignee: Mississippi State University
    Inventors: Janice E. Chambers, Howard W. Chambers, Edward C. Meek
  • PHENOXYALKYL PYRIDINIUM OXIME THERAPEUTICS FOR TREATMENT OF ORGANOPHOSPHATE POISONING
    Publication number: 20130172393
    Abstract: Phenoxyalkyl pyridinium oxime compounds for use in treating organophosphate poisoning.
    Type: Application
    Filed: May 12, 2011
    Publication date: July 4, 2013
    Inventors: Janice E. Chambers, Howard W. Chambers, Edward C. Meek